Effects of In-Home Addiction Treatment for First Responders
NCT ID: NCT03907709
Last Updated: 2019-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
15 participants
OBSERVATIONAL
2019-04-08
2020-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments
NCT01207791
Initiating Substance Use Disorder Treatment for Hospitalized Alcohol Use Disorder Patients
NCT04223011
Group Activities to Support Addiction Recovery
NCT07071883
Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting
NCT01661517
Brief Intervention in Primary Care for Problem Drug Use and Abuse
NCT00877331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First Responders in In-Home Addiction Treatment Program
\- First responders (individual who does or has worked as a police officer, fire fighter, corrections officer, military police, emergency medical technician, paramedic, parole or probation officer)
In-Home Addiction Treatment Program
* Treatment was delivered per treatment protocol
* Primary IHAT Care Team consisted of a licensed Care Coordinator (LPN, RN, MSW, LPC, or LMFT) and two Recovery Advisors
* Urine drug screens administered randomly
* Appointments were scheduled per protocol for 52 weeks
* Within first two weeks of care, all clients are provided an evaluation by a psychiatrist to ensure fitness for program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
In-Home Addiction Treatment Program
* Treatment was delivered per treatment protocol
* Primary IHAT Care Team consisted of a licensed Care Coordinator (LPN, RN, MSW, LPC, or LMFT) and two Recovery Advisors
* Urine drug screens administered randomly
* Appointments were scheduled per protocol for 52 weeks
* Within first two weeks of care, all clients are provided an evaluation by a psychiatrist to ensure fitness for program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Client enrolled in Aware Recovery Care after April 2017
* Client discharged from Aware Recovery Care before March 2019
* Client has primary substance use disorder diagnosis
Exclusion Criteria
* Client moved out of service area or lost insurance during care
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
In-Home Addiction Treatment Institute, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sara Kaiser, MS Ed, LPN
Role: PRINCIPAL_INVESTIGATOR
In-Home Addiction Treatment Institute, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aware Recovery Care
North Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IHATI-2019-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.